PUBLISHER: iData Research Inc. | PRODUCT CODE: 2133438
PUBLISHER: iData Research Inc. | PRODUCT CODE: 2133438
Please contact us using the inquiry form for pricing information.
The global neurological device market was valued at $12.2 billion in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 4.1%, reaching $16.1 billion by 2032.
This report covers cerebrospinal fluid (CSF) management devices, detachable coils, liquid embolics, neurovascular catheters, neurovascular guidewires, neurovascular stents, balloon occlusion devices, aneurysm clips, neurovascular thrombus management devices, neuromodulation devices, intrathecal pumps, stereotactic devices, and ultrasonic aspirators. It quantifies unit sales, procedure numbers, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.
The market is shaped by an aging global population that is increasing the incidence of conditions such as hydrocephalus and traumatic brain injury, and by the growing adoption of minimally invasive neurovascular intervention across endovascular and interventional settings. Emerging technologies including artificial intelligence, augmented reality, and cloud-based neuroimaging platforms are improving diagnostic precision, intraoperative navigation, and cross-facility care coordination, supporting broader adoption of advanced neurological procedures.
Key restraints include complications and revision burdens associated with CSF shunt systems and a historically slow pace of product innovation in the CSF management segment, where hospital budget constraints and limited commercial incentive have maintained a negative feedback loop between manufacturer investment and institutional adoption of new designs.
Market Overview
The global neurological device market is one of the largest and most diverse segments in medical technology, spanning cerebrospinal fluid management, endovascular neurovascular intervention, neuromodulation, and neurosurgical instrumentation. The market encompasses both high-volume consumable categories such as catheters and guidewires and high-value capital and implantable platforms such as deep brain stimulation systems and intrathecal pumps. This breadth means that growth drivers and commercial dynamics vary meaningfully across segments, with demographic trends, technology adoption, and reimbursement policy each playing different roles depending on the indication.
Emerging technologies are increasingly shaping market development across multiple device categories. Artificial intelligence and machine learning are enhancing diagnostic precision and procedural efficiency through advanced imaging analysis and predictive modeling, enabling earlier detection of neurological conditions and supporting more personalized treatment pathways. Augmented and virtual reality are improving neurosurgical training and intraoperative navigation by providing real-time three-dimensional visualization of patient anatomy. Cloud-based neuroimaging platforms are streamlining data management and enabling remote consultation and coordinated care, particularly when integrated with AI-driven analytics.
An aging global population is the primary demographic driver across multiple device categories. Hydrocephalus affects the elderly disproportionately, and as this demographic grows, demand for shunts and external drainage systems will rise. The annual number of traumatic brain injury cases is also increasing, supporting procedural volume growth across neurovascular and neurosurgical device categories. Chronic neurological conditions such as stroke, intracranial aneurysm, and movement disorders that benefit from neuromodulation therapy are similarly more prevalent in older populations, creating a durable demand base across several market segments.
The market for minimally invasive neurovascular procedures continues to grow as interventional platforms become more capable and clinical evidence accumulates. Endovascular approaches to aneurysm treatment, stroke intervention, and embolization are displacing open surgical techniques, driving demand for detachable coils, liquid embolics, flow diversion stents, stent retrievers, and aspiration catheters. Neuromodulation is also expanding through spinal cord stimulation and deep brain stimulation platforms that now offer personalized therapy programming and MRI compatibility, broadening the eligible patient population and supporting sustained segment growth.
Market Drivers
Demographic Factors
Hydrocephalus affects the elderly more frequently than other patient groups, and as the global population ages the incidence of this condition will rise, driving increased demand for shunts and CSF drainage products across both implantable and external drainage categories. These demographic dynamics are also expanding the external drainage system market as more patients develop conditions requiring active cerebrospinal fluid management. The number of traumatic brain injury cases occurring annually is increasing, further contributing to procedural volume growth across neurovascular and neurosurgical device categories. This aging and injury trend creates a sustained demand base across CSF management, thrombus management, neuromodulation, and related segments, supporting market growth that is largely independent of procedural technology adoption rates.
Advancing Technology
Emerging shunt technologies are making CSF management devices a more attractive treatment option for physicians, while advances in intracranial pressure monitoring are improving hydrocephalus diagnosis rates and expanding the identified patient population. Antimicrobial catheters represent the next significant innovation in the CSF shunt market, with antimicrobial coatings on distal catheter ends designed to reduce infection rates and the associated revision burden. These advances are expected to support higher ASPs in the CSF management segment and drive market value growth. More broadly, the integration of AI-driven imaging analysis, AR-assisted surgical navigation, and cloud-based neuroimaging is improving the precision and efficiency of neurological procedures across multiple indications, accelerating adoption of advanced device platforms throughout the market.
Market Limiters
Shunt Efficacy and Revision Burden
Hydrocephalus shunts are effective when functioning correctly, but they are subject to multiple complications that frequently require revision surgery. Shunts can become blocked, infected, or disconnected, causing symptoms to re-emerge. These symptoms range from mild presentations such as headaches, nausea, and vomiting to more serious complications including seizures and cognitive dysfunction. Most patients with hydrocephalus will require at least one revision procedure during their lifetime, exposing them to repeated surgical risk and placing a sustained procedural burden on the healthcare system that reflects complications rather than new indications. Patients with magnetic components in their shunts must also follow highly specific safety guidelines for MRI procedures, adding clinical management complexity and limiting diagnostic flexibility.
Lack of Innovation in CSF Management
Healthcare centers operate with limited budgets and are often hesitant to adopt more expensive, innovative products when existing options are considered clinically adequate. Since the hydrocephalus shunt was first introduced in the 1960s, the core design has changed very little beyond the introduction of adjustable pressure valves. This creates a negative feedback loop in which manufacturers are unlikely to invest in significantly improved products when institutional purchasing behavior does not reward innovation, and providers see little incentive to advocate for change when current products remain functional. Government initiatives, including potential policy spillover effects from the European Union, have the potential to disrupt this dynamic and encourage renewed investment in CSF management design, but meaningful innovation in this segment remains limited over the near-term forecast period.
Market Coverage and Data Scope
Markets Covered and Segmentation
Competitive Analysis
Medtronic holds the leading position in the global neurological device market in 2025, supported by a broad and well-diversified portfolio across multiple segments. The company demonstrates particularly strong dominance in cerebrospinal fluid management, liquid embolics, intrathecal pumps, and stereotactic devices, while also maintaining a leading presence in neuromodulation and neurovascular stents. Medtronic also competes effectively in thrombus management and detachable coils, reinforcing its position across both therapeutic and interventional applications. This extensive segment coverage, combined with the ability to hold strong positions across several high-value device categories, enables Medtronic to sustain its global market leadership.
Stryker holds the second-leading position in 2025, driven by strength in neurovascular and stroke-related interventions. The company demonstrates leadership in neurovascular guidewires and ultrasonic aspiration while also maintaining a competitive position in detachable coils, balloon occlusion, neurovascular stents, and thrombus management. Stryker's portfolio is focused on interventional solutions, positioning it to capitalize on the growing demand for minimally invasive neurovascular procedures. This targeted strength across key endovascular segments supports its standing as a major global competitor.
Boston Scientific ranks as the third-leading competitor in 2025, with its position largely supported by strength in neuromodulation. The company has advanced beyond its earlier Precision systems and expanded its spinal cord stimulation portfolio with platforms such as WaveWriter Alpha and Spectra WaveWriter, which offer multi-waveform capabilities and enhanced programming for personalized therapy. Ongoing enhancements including MRI compatibility and integrated digital features strengthen its competitive position and allow it to maintain a leading standing in the overall market despite narrower segment diversification relative to the two market leaders.
Technology and Practice Trends
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Neurological Device Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail. Use it to quantify demand, benchmark competitors, prioritize product development investments, and plan for growth across all major global regions.
Global Neurological Device Market Overview
Competitive Analysis
Emerging Markets And Technologies
Market Trends
Market Developments
Procedures Included
Markets Included
Regions Included
Key Analysis Updates
Key Report Updates
Version History
Global Neurological Device Market Overview
Please contact us using the inquiry form for pricing information.